At this year's BioVaria in Munich at the end of April, there was a session for very early start-up projects that will receive funding. After six founders presented their ideas to a larger life science community for the first time, our SPARKees from Myopax and an another team were honored by a jury of technology transfer experts for their outstanding presentations.
Congratulations!
Click here for more information.
